Technical Analysis for EIGR - Eiger BioPharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade C 11.55 -2.61% -0.31
EIGR closed down 2.61 percent on Wednesday, September 18, 2019, on 67 percent of normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Flat
See historical EIGR trend table...

Date Alert Name Type % Chg
Fell Below 200 DMA Bearish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
200 DMA Support Bullish -2.61%
New Uptrend Bullish -2.61%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.61%
Upper Bollinger Band Walk Strength -2.61%
Inside Day Range Contraction -2.61%
Crossed Above 200 DMA Bullish -3.19%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -3.19%
Upper Bollinger Band Walk Strength -3.19%

Older signals for EIGR ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Eiger BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops a portfolio of late-stage drugs for orphan diseases. It offers Sarasar, which is used for the treatment of hepatitis delta; Exendin that is used for the treatment of hypoglycemia; and Bestatin, which is used for the treatment of pulmonary arterial hypertension and lymphedema. Eiger BioPharmaceuticals, Inc. was founded in 2008 and is based in Palo Alto, California.
Biotechnology Biopharmaceutical Life Sciences Pharmaceutical Industry Pharmacy Pulmonary Arterial Hypertension Specialty Drugs Hepatitis Pulmonary Hypertension Orphan Diseases Hypoglycemia
Is EIGR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 15.33
52 Week Low 8.4
Average Volume 126,798
200-Day Moving Average 11.8026
50-Day Moving Average 10.7896
20-Day Moving Average 10.9955
10-Day Moving Average 11.545
Average True Range 0.5212
ADX 26.68
+DI 27.6498
-DI 16.0258
Chandelier Exit (Long, 3 ATRs ) 10.9356
Chandelier Exit (Short, 3 ATRs ) 11.283600000000001
Upper Bollinger Band 12.301
Lower Bollinger Band 9.69
Percent B (%b) 0.71
BandWidth 23.746078
MACD Line 0.3557
MACD Signal Line 0.262
MACD Histogram 0.0937
Fundamentals Value
Market Cap 96.64 Million
Num Shares 8.37 Million
EPS -5.68
Price-to-Earnings (P/E) Ratio -2.03
Price-to-Sales 0.00
Price-to-Book 4.37
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.51
Resistance 3 (R3) 12.52 12.20 12.35
Resistance 2 (R2) 12.20 11.96 12.20 12.30
Resistance 1 (R1) 11.88 11.81 11.72 11.87 12.24
Pivot Point 11.56 11.56 11.49 11.56 11.56
Support 1 (S1) 11.24 11.32 11.08 11.23 10.86
Support 2 (S2) 10.92 11.17 10.92 10.80
Support 3 (S3) 10.60 10.92 10.75
Support 4 (S4) 10.59